{"schema_version":"secwatch.filing_event.v1","accession":"0001516551-21-000031","form_type":"8-K","ticker":"SKYE","cik":"0001516551","company_name":"Skye Bioscience, Inc.","filed_at":"2021-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.826609+00:00","generated_at":"2026-06-27T23:40:46.844153+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Skye Bioscience appoints Dr. Keith Ward to board, promotes Tu Diep to CDO","bullets":["Dr. Ward elected to board; receives $40K annual director fee, $1K committee pay, and options for 250K shares vesting monthly over one year.","CEO Punit Dhillon granted 2,000,000 RSUs and 3,090,000 stock options at $0.058/share; Kaitlyn Arsenault granted 1,000,000 RSUs and 1,770,000 options.","Tu Diep promoted from SVP of Development to Chief Development Officer, effective immediately.","Options to Dhillon and Arsenault vest 25% at one year then monthly; fully vest on change of control; expire Dec 14, 2031."],"urls":{"canonical":"https://secwatch.observer/filing/0001516551-21-000031","json":"https://secwatch.observer/filing/0001516551-21-000031.json","markdown":"https://secwatch.observer/filing/0001516551-21-000031.md","text":"https://secwatch.observer/filing/0001516551-21-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1516551/000151655121000031/0001516551-21-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1516551/000151655121000031/skye-20211214.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T23:40:46.844153+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4d8b9e9b15","claim":"Keith Ward was elected as Director at Skye Bioscience, Inc..","evidence_excerpt":"elected Dr. Keith Ward, Ph.D. to fill such vacancy and serve as a director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655121000031/0001516551-21-000031-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}